William McClintock, a director of T Stamp Inc, filed a statement of changes in beneficial ownership on November 3, 2026, reporting the vesting of restricted stock units and acquisition of 52 shares of Class A Common Stock on October 31, 2026.
Cadeler A/S filed a Form 6-K on November 3, 2026, disclosing a major shareholding notification following the settlement of a share exchange offer through which Cadeler plc acquired approximately 92.06% of Cadeler A/S shares as part of a planned redomiciliation from Denmark to the …
LG Display Co., Ltd. filed a Form 6-K with the SEC on November 3, 2026, disclosing that the Korea Exchange designated the company an "Unfaithful Disclosure Corporation" that same day due to a delayed disclosure filing related to a suspicion of embezzlement or misappropriation.
A Form 4 filed on November 3, 2026, disclosed that Charles Edward Potts, a director of T Stamp Inc, acquired 1,034 derivative securities in a grant transaction dated October 31, 2026.
NIP Group Inc. Executive Vice President Tang Heng filed a Form 4 on November 3, 2026, disclosing the acquisition of 52,584,563 Class B1 ordinary shares on October 30, 2026, at a price of $0 upon vesting of restricted shares.
VNET Group, Inc. SVP of Operational Finance Zhang Zhihua filed a Form 4 on November 3, 2026, disclosing the vesting of 79,200 Class A ordinary shares from RSUs on October 31, 2026, and the subsequent sale of 28,740 shares on November 2, 2026.
Director Chen David Lifeng filed a Form 4 with the SEC on November 3, 2026, disclosing the vesting of 83,538 restricted share units in VNET Group, Inc. (NASDAQ:VNET) on October 31, 2026.
Nano Dimension Ltd. officer John Brenton filed a Form 144 notice of proposed sale on November 2, 2026, disclosing plans to sell 11,587 American Depositary Shares with an aggregate market value of $15,410.71 through Oppenheimer & Co. Inc.
Nuveen Churchill Direct Lending Corp. filed a Form 8-K on November 3, 2026, announcing the release of its financial results for the third quarter ended September 30, 2026, and disclosing a related earnings conference call held the same day.
Precision BioSciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026.